AbCellera Biologics Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
AbCellera Biologics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • AbCellera Biologics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $31M, a 98.7% increase year-over-year.
  • AbCellera Biologics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $106M, a 103% increase year-over-year.
  • AbCellera Biologics Inc. annual Nonoperating Income (Expense) for 2023 was $63.2M, a 180% increase from 2022.
  • AbCellera Biologics Inc. annual Nonoperating Income (Expense) for 2022 was $22.6M, a 53.3% increase from 2021.
  • AbCellera Biologics Inc. annual Nonoperating Income (Expense) for 2021 was $14.7M, a 718% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $63.2M +$40.6M +180% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $22.6M +$7.85M +53.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $14.7M +$12.9M +718% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $1.8M -$104K -5.46% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $1.91M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.